Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND Increasing emergence of antimicrobial resistance worldwide has led to renewed interest in phage therapy. Unlike antibiotics, the lack of pharmacokinetics/pharmacodynamics (PK/PD) information represents a major challenge for phage therapy. As therapeutic phages are biological entities with the ability to self-replicate in the presence of susceptible bacteria, their PK/PD is far more complicated than that of antibiotics. OBJECTIVES This narrative review examines the current literature on phage pharmacology and highlights major pharmacological challenges for phage therapy. SOURCES Included articles were identified by searching PubMed and Google Scholar till June 2022. The search terms were "bacteriophage", "antimicrobial", "pharmacokinetics" and "pharmacodynamics". Additional relevant references were obtained from articles retrieved from the primary search. CONTENT In this review, phage PK is firstly discussed, focusing on absorption, distribution, metabolism and elimination. Key factors affecting phage antimicrobial activities are reviewed, including multiplicity of infection, passive and active phage therapy, and the involvement of the human immune system. Importantly, we emphasise the impact of phage self-replication on the PK/PD and the fundamental phage characteristics that are required for PK/PD modelling and clinical translation. IMPLICATIONS Recent progress in phage pharmacology has shown that we are in a far better position now to treat infections with phage therapy than a century ago. However, phage therapy is still in its infancy when compared to antibiotics due to the scarce pharmacological knowledge (e.g., PK/PD). Optimisation of phage PK/PD is the key for translation of phage therapy in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 1,180
Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
Van Belleghem, J. D., Dąbrowska, K., Vaneechoutte, M., Barr, J. J., & Bollyky, P. L. (2018) · Viruses · doi:10.3390/v11010010 · Cited by 408
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection
Little, J. S., Dedrick, R. M., Freeman, K. G., Cristinziano, M., Smith, B. E., Benson, C. A., Jhaveri, T. A., Baden, L. R., Solomon, D. A., & Hatfull, G. F. (2022) · Nature Communications · doi:10.1038/s41467-022-29689-4 · Cited by 128
Cited by
Regulation of phage therapy medicinal products: developments, challenges, and opportunities
Fuerst-Wilmes, M., Respondek, V., Schramm, M., Lilienthal, N., Buss, K., & Duechting, A. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1631359 · Cited by 31
Metadata
- Authors
- Nang, S. C., Lin, Y.-W., Petrovic Fabijan, A., Chang, R. Y. K., Rao, G. G., Iredell, J., Chan, H.-K., & Li, J.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 29
- Issue
- 6
- Pages
- 702-709
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W4319015598
- Cited by
- 161
- References
- 3
- FWCI
- 25.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.